Webinar Video | Life Sciences Session #1: What’s new in the parallel world of parallel trade?

Webinar Video | Life Sciences Session #1: What’s new in the parallel world of parallel trade?
November 24, 2020

In our first Life Sciences Session, our experts Philippe de Jong and Kirian Claeyé talk you through a number of recent decisions and developments in the field of parallel trade of pharmaceuticals, medical devices and plant protection products, including:

  • The rebranding of generics to original brand reference products
  • The impact of the falsified medicines framework on parallel trade
  • Further points of attention when verifying in light of the BMS conditions


  • Philippe de Jong


  • Kirian Claeyé


Recommended articles

September 27, 2023

Kirian Claeyé promoted to partner at ALTIUS

ALTIUS is delighted to announce that Kirian Claeyé has been promoted to partner as per September 2023. Congratulations Kirian!

Read on
September 05, 2023

The Belgian Competition Authority has declared itself competent to examine mergers and acquisitions between hospitals under its merger control regime, following the Act of 29 March 2021

A lot of uncertainty has existed about the requirement for hospitals to notify M&A transactions to the Belgian Competition Authority (“BCA”). On 28 June 2023, the BCA decided to partially lift the stand-still obligation regarding a concentration between two hospitals, and it further clarified the applicable rules in a follow-up Communication of 14 July 2023.

Read on
July 03, 2023

WEBINAR VIDEO | The New EU Deforestation Regulation: Stay Compliant, Succeed Sustainably

In this Life Sciences session, the experts from our agri-food law team Philippe de Jong and Bart Junior Bollen provided valuable insights into the Regulation's implications and equiped businesses with the necessary knowledge to ensure compliance in this evolving landscape.

Read on